Genocea Biosciences (GNCA) Announces Proposed 10M Share Common Offering
Get Alerts GNCA Hot Sheet
Join SI Premium – FREE
Genocea Biosciences, Inc. (NASDAQ: GNCA) today announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock. All the shares in the offering will be sold by Genocea. In addition, Genocea expects to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock sold in the public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
SVB Leerink and Stifel are acting as joint book-running managers for the offering. Baird and Needham & Company are acting as co-managers for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Praxis Precision Medicines (PRAX) Announces Proposed Share Offering
- Celcuity Inc (CELC) PT Raised to $24 at Needham
- SELLAS Life Sciences (SLS) Announces 13.03M Share Offering by Selling Stockholders
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Stifel, Robert W Baird, Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!